Company Profile

MedImmune

Company Overview

With one of the largest, most robust pipelines in the industry — including more than 120 research projects and product candidates — MedImmune comprises nearly half of AstraZeneca’s overall R&D portfolio. We are focused on three core therapeutic areas: Oncology; Respiratory, Inflammation and Autoimmune; and Cardiovascular and Metabolic Disease. But, we also are opportunity-driven in Infectious Disease.

Positions Available
This company currently has no jobs posted.

Click here to search for jobs.